These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21600528)

  • 1. Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Ito MK; McGowan MP; Moriarty PM;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S38-45. PubMed ID: 21600528
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Robinson JG; Goldberg AC;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S18-29. PubMed ID: 21600526
    [No Abstract]   [Full Text] [Related]  

  • 4. HELP LDL-apheresis in two cases of familial hypercholesterolemic pregnant women.
    Anedda S; Mura S; Marcello C; Pintus P
    Transfus Apher Sci; 2011 Feb; 44(1):21-4. PubMed ID: 21257349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis.
    Hemphill LC
    J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S1-8. PubMed ID: 21600525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance.
    Thorogood M; Seed M; De Mott K;
    BJOG; 2009 Mar; 116(4):478-9. PubMed ID: 19250359
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosorptive apheresis of LDL.
    Borberg H; Gaczkowski A; Oette K; Stoffel W
    Prog Clin Biol Res; 1990; 337():163-7. PubMed ID: 2191310
    [No Abstract]   [Full Text] [Related]  

  • 9. [LDL-adsorption therapy of familial hypercholesterolemia].
    Kobayashi J; Yoshida S
    Nihon Rinsho; 1992 Jan; 50 Suppl():382-7. PubMed ID: 1578711
    [No Abstract]   [Full Text] [Related]  

  • 10. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Robinson JG; Cromwell WC; Ross JL; Ziajka PE
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S46-51. PubMed ID: 21600529
    [No Abstract]   [Full Text] [Related]  

  • 15. Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body in familial hypercholesterolemia.
    Jin H; Yao F; Li ZG; Xu ZY
    Thorac Cardiovasc Surg; 2009 Aug; 57(5):303-4. PubMed ID: 19629894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia.
    Ramunni A; Brescia P; Dambra P; Capuzzimati L; Ria R; De Tullio G; Resta F; Russi G; Vacca A; Coratelli P
    Blood Purif; 2010; 29(4):383-9. PubMed ID: 20484899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LDL apheresis].
    Homma Y
    Nihon Rinsho; 2004 May; 62 Suppl 5():590-4. PubMed ID: 15197990
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the management of lipid disorders. Toronto, Ontario, October 4.
    Can J Cardiol; 1988; 4(8):VI-VIII. PubMed ID: 3228768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.